• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Haemato-Oncology
    • Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial

    View/Open
    Accepted version (120.4Kb)
    Volume
    31
    Pagination
    58 - 64
    DOI
    10.1038/leu.2016.219
    Journal
    LEUKEMIA
    Issue
    1
    ISSN
    0887-6924
    Metadata
    Show full item record
    Authors
    Patel, B; Kirkwood, AA; Dey, A; Marks, DI; McMillan, AK; Menne, TF; Micklewright, L; Patrick, P; Purnell, S; Rowntree, CJ
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/18902
    Collections
    • Centre for Haemato-Oncology [157]
    Copyright statements
    (c) The Author(s), 2016
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.